6 results
Evaluation Algorithm of Patients with Bleeding

#Differential #Bleeding #Superficial #Deep #Causes #Algorithm #Hematology
Evaluation Algorithm ... Patients with Bleeding ... #Differential #Bleeding ... #Deep #Causes #Algorithm ... #Hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
incidental DVT or PE in cancer ... thrombosis in cancer ... at high risk of bleeding ... interactions and bleeding ... #Management #Hematology
The 6 C’s of Primary Sclerosing Cholangitis (PSC)
PSC is a chronic, cholestatic, immune-mediated disease characterized by
ducts, commonly leading ... without PSC • CANCER ... hepato-biliary cancers ... clinical trial evaluation ... management #summary #Hepatology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Thromboembolism Treatment Algorithm ... PE - High Bleeding ... - Not High Bleeding ... Thromboembolism #Treatment #Algorithm ... #management #hematology
Helpful Clinical Features in Evaluating Bleeding Disorders
Age of onset
 • Neonate - in 20% of haemophilias,
Clinical Features in Evaluating ... Bleeding Disorders ... haemophilias, bleeding ... pediatrics #diagnosis #hematology ... #primarycare
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... From Blood Cancer ... risk of clonal evolution ... an infection or bleeding ... #algorithm #hematology